Pharmacological protection of the myocardium with reamberin in coronary artery bypass grafting in patients with postinfarction angina

Georgiy Ivanovich Sidorenko; Сидоренко Георгий Иванович; Lyudmila Grigor'evna Gelis; Гелис Людмила Григорьевна; Elena Aleksandrovna Medvedeva; Медведева Елена Александровна; Yuriy Petrovich Ostrovskiy; Островский Юрий Петрович; Irina Valentinovna Lazareva; Лазарева Ирина Валентиновна; Tat'yana Vasil'evna Sevruk; Севрук Татьяна Васильевна; Natal'ya Aleksandrovna Shibeko; Шибеко Наталья Александровна; Yuriy Petrovich Petrov; Петров Юрий Петрович; G I Sidorenko; Sidorenko G I; L G Gelis; Gelis L G; E A Medvedeva; Medvedeva E A; Yu P Ostrovsky; Ostrovsky Yu P; I V Lazareva; Lazareva I V; T V Sevruk; Sevruk T V; N A Shibeko; Shibeko N A; Yu P Petrov; Petrov Yu P

Pharmacological protection of the myocardium with reamberin in coronary artery bypass grafting in patients with postinfarction angina

作者: Sidorenko G.I.¹, Gelis L.G.¹, Medvedeva E.A.¹, Ostrovskiy Y.P.¹, Lazareva I.V.¹, Sevruk T.V.¹, Shibeko N.A.¹, Petrov Y.P.¹, Sidorenko GI², Gelis LG², Medvedeva EA², Ostrovsky Y.P², Lazareva IV², Sevruk TV², Shibeko NA², Petrov Y.P²
隶属关系:
1. Республиканский научно-практический центр "Кардиология", Минск, Республика Беларусь
2. Republican Research and Practical Center "Cardiology", Minsk, Republic of Belarus
期: 卷 83, 编号 9 (2011)
页面: 35-40
栏目: Editorial
URL: https://journal-vniispk.ru/0040-3660/article/view/30909
ID: 30909

如何引用文章

详细

Aim. To assess efficacy of reamberin in preoperative preparation and after coronary bypass (CB) in patients with macrofocal myocardial infarction (MI) complicated with postinfarction angina.
Material and methods. A total of 45 patients with Q-positive MI complicated with postinfarction angina pectoris entered the trial. The study group consisted of 20 (44.4%) patients given 200-400 ml injections of 1.5% reamberin solution for 3 days before coronary artery bypass grafting (CABG) and 3-5 days after it. The control group consisted of 25 (55.6%) patients given basic therapy without cardioprotection. ECTG-60, echocardiography, CM-ECG, laboratory tests were made before CABG. CABG was made in conditions of artificial blood circulation in all the patients.
Results. Clinical stabilization was observed after direct myocardial revascularization in hospitalized 25 (100%) patients of the study group and 22 (88%) patients of the control group. Early postoperative acute cardiac failure (ACF) developed in 3 (12%) patients from the study group and 9 (36%) from the control group (p = 0.04), arrhythmia occurred in 2(8%) and 8(32%) patients, respectively (p = 0.03). Two (8%) control patients died in early postoperative period from acute cardiac failure. Perioperative MI occurred in 2(8%) control patients. After 12 months of the follow-up, patients of the study group had no recurrent angina pectoris, while among the controls 4(16%) patients had recurrent angina of FC III. After surgical intervention at discharge and 12 months after treatment patients of both groups improved systolic and diastolic functions of the left ventricle. Normalization of the diastolic function was registered in 80% patients of the study group (p < 0.001) and in 44% from the control group (p < 0.001) after 1 year follow-up.
Conclusion. Reamberin reduces the number of postoperative complications, ischemic damage to the myocardium, significantly improves systolic and diastolic functions of the left ventricle.

关键词

coronary artery bypass grafting, postinfarction angina pectoris, reamberin, postoperative complications

参考

Бокерия Л. А., Маликов В. Е., Сигаев И. Ю. и др. Системы энергетического обеспечения, ПОЛ и лизосомальных ферментов при трансмиокардиальной лазерной реваскуляризации и ее сочетании с аортокоронарным шунтированием. Бюл. экспер. биол. 2002; прил. 2: 40-43.
Мазина Н. К., Мазин П. В., Хазанов В. А. Некоторые теоретические и прикладные аспекты системного действия регуляторов энергетического обмена. В кн.: Регуляторы энергетического обмена. Клинико-фармакологические аспекты. Матер. V Всероссийского симпозиума. XIII Российский нац. конгресс "Человек и лекарство". М.; Томск, 2006: 93-101.
Маликов В. Е., Сукаян Г. В., Юситов А. С. Способы кардиопротекции при хирургической реваскуляризации миокарда. М.: Изд-во НЦССХ им. А. Н. Бакулева РАМН; 2005. 56.
Пархоменко А. Н., Иркин О. И., Кожунов С. Н. Возможности фармакологической защиты миокарда при синдроме ишемии-реперфузии в эксперименте и клинической практике. Лiкi Украiни 2002; 7-8: 2-11.
Сидоренко Г. И., Комиссарова С. М. и др. Опыт применения актопротектора реамберина в клинике кардиохирургии. Клин. фармакол. и тер. 2007; 3: 39-43.
Шабалин А. В., Никитин Ю. П. Защита кардиомиоцита. Современное состояние и перспективы. Кардиология 1999; 78 (3): 4-10.
Beller G. A. Diagnostic accuracy of thallium-201 myocardial perfusion imaging. Circulation 1991; 84 (3): 11-16.
Charney R., Schwinger M. E., Chun J. et al. Dobutamin echocardiography and resting-redistribution Thallium-201 scintigraphy predicts recovery of hibernating myocardium after coronary revascularization. Am.Heart J. 1994; 128: 864- 869.
Gibson R. S., Watson D. D., Taylor G. J. Prospective assessment of regional myocardial perfusion befor and after coronary evascularization surgery by quantitative thallium-201 scintigraphy. J. Am. Coll. Cardiol. 1983; 1: 804-815.

补充文件

附件文件

动作

1. JATS XML

下载

用户名
密码
记住我

忘记您的密码?	注册

用户名
密码
记住我

忘记您的密码?	注册

Pharmacological protection of the myocardium with reamberin in coronary artery bypass grafting in patients with postinfarction angina

全文:

详细

关键词

作者简介

Georgiy Sidorenko

Lyudmila Gelis

Elena Medvedeva

Yuriy Ostrovskiy

Irina Lazareva

Tat'yana Sevruk

Natal'ya Shibeko

Yuriy Petrov

G Sidorenko

L Gelis

E Medvedeva

Yu Ostrovsky

I Lazareva

T Sevruk

N Shibeko

Yu Petrov

参考

补充文件